At this year’s annual EuroPCR meeting, Boston Scientific (NYSE:BSXtouted results from the first trial to compare two drug-coated balloons with different drug formulations – Boston Scientific’s Agent paclitaxel-coated PTCA device and B. Braun’s SeQuent Please balloon.
The 125-patient study evaluated the balloons in patients with in-stent restenosis of a lesion previously treated with a drug-eluting stent or drug-coated balloon.
Get the full story at our sister site, Drug Delivery Business News.
The post EuroPCR 2018: Study compares drug-coated balloons in patients with arterial in-stent restenosis appeared first on MassDevice.